Cidara Therapeutics, Inc.

GEODE CAPITAL MANAGEMENT, LLC

Report date

3/31/2024

Quarter

2024 Q1

Filed

5/13/2024

Shares

838,286

Value ($000)

771

Weight

0.0%

2019 Q4 - 2024 Q1 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q1	5/13/2024	771	0.0%	838,286	3/31/2024
2023 Q4	2/13/2024	640	0.0%	805,871	12/31/2023
2023 Q3	11/13/2023	759	0.0%	805,871	9/30/2023
2023 Q2	8/11/2023	822	0.0%	727,710	6/30/2023
2023 Q1	5/15/2023	838	0.0%	659,667	3/31/2023
2022 Q4	2/13/2023	448	0.0%	592,724	12/31/2022
2022 Q3	11/14/2022	367	0.0%	584,981	9/30/2022
2022 Q2	8/12/2022	245	0.0%	502,049	6/30/2022
2022 Q1	5/13/2022	396	0.0%	476,076	3/31/2022
2021 Q4	2/11/2022	484	0.0%	381,618	12/31/2021
2021 Q3	11/12/2021	854	0.0%	381,618	9/30/2021
2021 Q2	8/13/2021	735	0.0%	364,162	6/30/2021
2021 Q1	5/12/2021	1,570	0.0%	590,368	3/31/2021
2020 Q4	2/12/2021	911	0.0%	455,736	12/31/2020
2020 Q3	11/13/2020	1,276	0.0%	448,082	9/30/2020
2020 Q2	8/13/2020	1,619	0.0%	438,754	6/30/2020
2020 Q1	5/14/2020	545	0.0%	220,009	3/31/2020
2019 Q4	2/13/2020	452	0.0%	117,738	12/31/2019